Deciding to undergo a predictive genetic test is difficult. The patient has no symptoms that might tip the balance in favor of the test, and knowledge of the information might have significant implications for her physical and mental health, her family, and her financial position. Furthermore, although the decision to undergo many medical tests might reasonably be said to be the patient's own business, it could be argued that predictive genetic tests are different. Dean Bell and Belinda Bennett argue that genetic information has a “shared” or “familial” character due to the likelihood of it affecting others.Footnote 1 If others might be affected by the results of your test, then it is certainly plausible to suggest that they have an interest in knowing the information. If that is the case, then it could also be argued that they are entitled to be considered when you are deciding whether to undergo a test.
Unfortunately this rather glib statement conceals a number of more complicated questions, of which I have chosen two to focus on: Who is entitled to be considered and on what basis? What does this entitlement mean for the decisionmaker?
In this paper, I hope to shed some light on the first of these issues, although I address the second as well. I begin by considering Mill's harm principle and then propose a framework to assist in identifying those who are entitled to consideration. Their entitlement is based on the type and strength of their connection to the decisionmaker.
The Harm Principle
John Stuart Mill asserted that the only reason for restraining the actions of individuals should be to avoid harming others. When he was formulating this “harm principle,”Footnote 2 Mill left two issues largely unaddressed: the nature of harm and the identity of the others whom our actions could be restrained to protect. The question of the nature of the necessary harm is one that has been discussed at great length,Footnote 3 and not one that will be addressed in this paper. The second issue has been dealt with much less frequently, but is, I think, worth some consideration.
Mill intended his harm principle to “govern absolutely the dealings of society with the individual.”Footnote 4 Although I make no comment on this intention, I think we can accept that the harm principle could be considered an appropriate method to deal with individual decisionmaking. On this basis, a decision would be inappropriate if another person would be harmed as a result of the choice made. Theoretically at least, we could be restrained from making a specific decision if this was the case. Who, then, is a relevant other? Mill, himself, does not narrow down the categories beyond “our fellow creatures.”Footnote 5 I would suggest that if we contextualize the question, then we can arrive at a more appropriate construction of who might qualify as a relevant other. On this basis, it can be argued that other people are relevant if they could be harmed by your decision or action. So, if a person might suffer harm as a result of your decision, then she would expect to be considered when you were deciding. Conversely, you would expect to be considered if she were deciding. Whether harm would actually be suffered is the second part of the process. I would argue that mere possibility of harm is sufficient to grant an entitlement to be considered.
Should I Have a Predictive Genetic Test?
Let us consider, then, how this might help our person deciding whether to undergo predictive genetic testing. It is trite to say that there are many different types of decisions and that many different people could be affected by those decisions. But, once we have identified a specific type of decision to be made, such as the decision whether to have a genetic test, then we can identify the groups of people who have a prima facie right to be considered when the decision is made.
In answer to the question, “Who should know about our genetic makeup and why?”Footnote 6 Tuija Takala and Heta Gylling identify four distinct groups of people:
i) me
ii) those people who are or who could be genetically linked with me
iii) those people with whom I contract, for example, my employer or insurer
iv) society at large.
I think it is important to note that they were asking a different question: “Who should know?” as opposed to my question, “Who should I think about when I choose whether to know?” Thus it is not immediately clear that the answer to my question should be the same as the answer to their question. However, it is certainly appropriate to consider their conclusions.
I would argue that their framework does not produce an entirely satisfactory answer to my question. Although there are good reasons to argue that I should consider myself as part of the decisionmaking process, it does not seem appropriate to define myself as an other—personal identity issues aside.Footnote 7 The most important problem is that their second group includes both my spouse and my children. They suggest that, by having children, your spouse or partner becomes genetically linked to you. They seem to equate this type of connection with that connection we have with our parents and children. As I hope to show further on, there are different considerations for these groups, and conflating the two masks this. I would also suggest that groups iii and iv might be better understood if put together. The difference makes more sense if it is understood as a matter of degree, rather than substance.
Who Is Relevant?
Takala and Gylling do not explain how they identified their four groups of interested parties. I think that they missed a trick. If we can understand why certain groups are relevant, or why certain groups are more relevant than others, then it will be easier to explain why someone has a right to be considered or a right to know. I would suggest that, in the case of genetic testing, a person's relevance to the decision depends on their relationship to the decisionmaker. The test I wish to propose has two constituent parts: The first is the nature of the relationship and the second is the proximity of that relationship.
The reason that we are trying to identify the relevant others is because our decisionmaker could be prevented from making a decision if it will harm one of these others. The nature of the relationship is important because a decision about knowledge of a genetic condition may harm different types of peopleFootnote 8 in different ways, and in many situations these harms will not overlap. This stage of the test identifies all the people who might need to be considered. The second stage, the proximity test, highlights whether it is likely that they would be harmed. Both arms of the test must be met in order for another person to qualify as a relevant other.
At the beginning of this paper I raised two questions: Who is entitled to be considered and on what basis and what does this entitlement mean for the decisionmaker? The nature of the relationship goes to this first question and identifies who and the basis of their entitlement. The proximity of their relationship goes to the meaning of their entitlement for the decisionmaker. It is the proximity that gives us some idea how much weight the decisionmaker should give to the others identified in the first stage of the test.
Applying the Test
What Is the Nature of the Relationship?
In the context of questions about genetic information, I would argue that there are three relevant ways in which a person could be connected to the decisionmaker. My categories correspond loosely with the groups identified by Takala and Gylling. I suggest that a relationship may be
i) biological
ii) emotional
iii) financial.
The biological group includes all those who are biologically related to us: our lineal antecedents, lineal descendants (including the unborn), and our siblings, aunts, uncles, and cousins. The importance of this connection is that our biological relatives may share parts of our genetic makeup, and thus may be at the same riskFootnote 9 as us. Prima facie, they must feature on our radar when we begin to make these decisions.
The emotional group contains all those who care about us and who may be affected if we were to become ill. They might be the people who look after us in our infirmity or the people who attend our funeral. The members would include our spouse, civil partner, or partner and our stepchildren or adoptive children. It would include our relations by marriage (our in-laws) and our friends. The fact that an emotional connection could exist will satisfy the first arm of the test, but the “crunch” will be in the proximity test.
The financial group includes anyone with whom we make a financial arrangement. This could be direct or indirect. Those with a direct financial relationship to us include our employer, insurer, credit card company, mortgage company, and bank. Essentially, this group may suffer financial harm as a result of any decision that might be made. We have indirect financial relationships with much of society, for example, in the United Kingdom, the National Health Service, which will have to care for us should we become ill. In addition, if we were to become ill and be unable to work, then we may be eligible for social security payments from the state, such as Incapacity Benefit.
How Proximate Is That Relationship?
The proximity test is really the crux of the matter. It is quite simple to show that a relationship exists. The newsagent you buy your morning newspaper from may be able to show a financial relationship with you. He may be able to show an emotional relationship if you are particularly friendly, but the existence of a connection does not imply that harm will undoubtedly be suffered.
The proximity test asks how close the relationship is. Essentially, the question is the likelihood that a connected person might suffer harm as the result of a decision. The actual calculation of harm is made at a later point. This test just qualifies someone for consideration.
In the biological group there are obvious classes. Your parents and children fall in the first category. You received half your genes from your father and half from your mother. If you are susceptible to a genetic risk, then it is likely that one of your parents will also be at risk. For example, if your maternal grandfather died from Huntington's Chorea, your mother has a 1/2 risk of having the genetic predisposition, and you have a 1/4 risk. Because this is a dominant genetic condition, if you are positive for the gene, then you will know that your mother is also positive for the gene. I would argue that the possibility of presymptomatically diagnosing your mother's Huntington's Chorea makes her relationship sufficiently proximate to justify consideration as an other. Then there are your children. They share half of your genes. If you know your risk of Huntington's to be 1/4, then your children each have a risk factor of 1/8. As soon as you know whether you are positive or negative for a particular predisposition, your children's risks will change to 0 (if you are negative) or 1/2 (if you are positive). This is a significant change that identifies their relationship as sufficiently proximate for consideration.
The second tier includes your siblings. Like you, they have half their genes from your mother and half from your father. In the Huntington's Chorea example, your siblings have a 1/4 risk. If you were found to be positive, then your siblings' risk factors would increase from 1/4 to 1/2.Footnote 10 They would then be in a position similar to yours, regarding a decision to be tested. Their children, your nieces and nephews, would be put in the same position as your children. I would suggest that this means the relationship you have with the second tier is proximate enough that they should be considered when you make your decision.
The third tier is made up of your aunts, uncles, and cousins. In the Huntington's example, your mother's siblings have the same risk factor as her, 1/2. Your father's siblings are at no risk because they are not genetically related to your mother. Your result will not have any effect on their risks. Your cousins are in the same position as you. Their parent has a risk factor of 1/2, so they have a risk factor of 1/4. Their risk factor will not change until their parent is diagnosed. Your test will not affect them either. However, your test will provide additional information that might assist them in deciding whether to be tested or not. Although this group clearly has some proximity, in this example their claim for consideration is relatively weak. They are not directly affected by your decision; their risk factors are not changed by a change in your risk factor. It may be the case that if Auntie Muriel is thinking about having the test herself and is interested in the result of your test, then you may wish to tell her how you fared, or if Uncle Nigel does not want to know, then you do not inform him about your test. In the biological sense, I think it is fair to say that these relationships are not sufficiently proximate to require much consideration from you when making your decision. This might change, however, if the example were different. Very few genetic conditions are as clear-cut as Huntington's. Many conditions need family linkage studies to identify them, and knowing about Auntie Muriel's condition might be crucial for your test and vice versa. The context in which the test is being taken is crucial to the proximity calculation for the biological group.
The proximity of members of the emotional group is entirely dependent on the closeness of their relationship to you. There cannot be clear-cut categories in this group, and it is not possible or sensible to create criteria for proximity. The closeness of an emotional relationship does not depend on how often you visit me or whether you send me a birthday card, and any such criteria would be artificial. Unlike biological connections, which can all be defined in a standard way, emotional relationships are all different. Only the individual concerned knows how important her relationships are and which of those she should consider.
All I can do, then, is identify those people who may be important. The most relevant members of this group are nongenetic relatives and friends. They are at risk of emotional harm as a result of your potential illness. They care about you and will be sad about your condition. They may also be the ones that care for you toward the end and who, therefore, may have to take time away from work. For every person in this group, the individual deciding will know which ones are sufficiently proximate and which ones are not. It might be argued that the type of harm that this group could suffer can only give a weak claim to be considered. There is no risk to their own health. The emotional harm they might suffer will be worrying and upsetting for them, but, from the decisionmaker's perspective, it is less important than the potential risks to her own health.
However, the spouse or partner does require some special mention. I make no comment on the quality of this particular relationship, nor do I assume that all decisionmakers have a relationship of this nature, but I suggest that a partner or spouse is different from the other members of this group because of the possibility of having children together.Footnote 11 Information about your genetic condition will be relevant to your partner's reproductive choices. This gives your partner a strong claim to consideration when you decide whether to undergo genetic testing. I suggested earlier that the biological group includes your unborn children. According a strong entitlement to your partner offers some protection for those potential children. If, however, children have already been born, then they would have their own right to consideration as members of the biological group. The argument giving a stronger right to the partner clearly depends on the fact that you have not yet had children. If, at the time of testing, there is no likelihood that you will have children together or have more children together, then the strength of the partner's claim would be reduced.
It might be interesting to consider briefly whether their gender makes any difference to the strength of a spouse or partner's claim to be considered when you decide whether to undergo genetic testing. With regards to any moral obligation to future children, I cannot, at the moment, argue that there is anything stronger than a duty not to have children whose lives would not be worth living. Given that both parents must ordinarily be involved in the procreation of a child, I would suggest that any moral obligation with regards to future children would be equally weighted between both the male and female parents. However, from a legal and practical point of view, this cannot be the whole answer. At least for the foreseeable future, the female partner will be the one responsible for gestating any child. Her bodily integrity, and thus her legal right to decide whether to continue a pregnancy to term, must give her a weightier entitlement to consideration than her male counterpart. Furthermore, if the genetic condition in question were one for which preimplantation genetic diagnosis might be available, it would be the woman who would face ovarian stimulation and numerous cycles of in vitro fertilization. This additional burden on the female partner must give her a stronger right as a Millian other. A similar argument could be made for conditions where prenatal diagnosis and abortion are the only options. The possibility of having to abort a wanted child is a serious enough consequence, with the potential for both physical and emotional harm, to award a strong right to consideration to a female partner. Clearly this is highly dependent on context, and the specifics of the genetic test, and the condition, in question may tip the balance.Footnote 12
The proximity of the financial group members is also dictated by the closeness of the relationship, although clearly this is not the same sort of closeness as in the emotional group. The newsagent you buy your newspaper from every morning could argue that you have a financial relationship that gives him a right to consideration. I think we can all agree that this relationship does not give the newsagent a strong claim to your consideration. At the other end of the spectrum is your employer, who has a much more significant financial relationship with you. If your test results could affect your ability to work, then you may be obligated to tell your employer. This is not a sanction—if you might be unable to perform your duties, then you may choose to tell your employer. There are often very good reasons why you should do this. The problem with these stronger direct financial relationships is identifying who might be harmed. In a number of cases you will be the one that might be disadvantaged. You might suffer problems at work; you may find that some financial products are no longer available to you. You may find it impossible to buy an insurance policy. This makes financial relationships very difficult to deal with. In one respect they are sufficiently proximate that you may need to consider them when you make your decision. However, you are the one who may suffer harm. In these cases you must balance the harm you may suffer as a result of not knowing against the harm you may suffer as a result of knowing. In another respect, they are less important than your emotional and biological relationships and thus are much less relevant to the decision you have to make.
Those with whom you have indirect financial arrangements are slightly different. The NHS may indeed have to provide medical care for you throughout your condition; they may also have to pay for your genetic test. But this is the purpose of the NHS—to provide healthcare from cradle to grave. One of its main aims is to provide access to healthcare that is free at the point of delivery. It is underpinned by a principle of equity—equal service for equal need.Footnote 13 The financial implications of your test are not something that you should consider when deciding whether to be tested. The NHS is there to provide you with the healthcare you need. If you meet the eligibility criteria for predictive genetic testing, then the test will be paid for.
The same is true for the situation where you may be entitled to assistance from the state. Although the social security pot is not bottomless, the reason for having a welfare state is to provide help to those who need it. If you are unable to work due to incapacity, then you are entitled to Incapacity Benefit, and possibly some other support from the state. You should not consider this a barrier to taking a test—this is something you are entitled to. The state is not harmed by your choice to be tested, it merely has to perform the duty for which it was created.
What Does This All Mean for Our Decisionmaker?
This framework should allow the decisionmaker, and others, to identify who else will be relevant to a decision they must make. Although the framework has been considered in the context of decisions to undergo genetic testing, I see no reason why my nature and proximity test would not be of use in the context of other decisions affecting others.
The framework does not provide a solution to the question of whether to undergo a genetic test or not. It only provides a structure to help identify who else should be considered as part of the decision. Nor does it offer any assistance with the weight that should be given to the interests accorded to the others identified. The test acknowledges that these decisions can only really be left to the individual to make the final choice. In the context of genetic testing, some other people will clearly be more relevant to the decision than others: those whose health could be affected by the decision and those whose reproductive choices will be affected. At least objectively, difficulties with these parties can be easily resolved. A candid conversation can go a long way, and, although it might result in painful choices, it should lead to the best solution.
More difficult to deal with are the problems that come from financial relationships. The issue with these relationships is not the possibility of harm to others. In reality no other entity will be substantively harmed by one person's decision to undergo genetic testing. Any harm resulting from a financial relationship will be suffered by the decisionmaker. The financial relationships that pass the proximity test are the ones characterized by an uneven balance of power: banks, mortgage lenders, insurance companies, and employers. In these relationships the larger player protects its own interests by passing any consequences on to the individual, who is not so able to protect her own interests.
With regards to our decisionmaker's financial relationships, the question she is faced with is about the lesser of two evils. Is it better to remain ignorant of any genetic issues and remain in a stable financial situation or to risk financial instability but have some certainty about her health?
I cannot answer the question, and it is important to recognize that only the decisionmaker can really know what to do. The nature and proximity test is a tool to make it simpler to decide who is important. I hope that it succeeds.
